MedicalCountermeasures.gov can help you keep up-to-date on the latest developments in federal medical countermeasures activities, with information on public meetings and conferences, procurement and grant opportunities, strategies, reports, federal guidance on the development of medical countermeasures, and other announcements.
- Procurements and Grants
Provides links to resources on grants and procurement opportunities available to those involved in the research, development and acquisition of medical countermeasures products, including Grants.gov, and grants available through the National Institutes of Health. Links to information on federal acquisition regulations are also available on this page.
- Public Meetings and Conferences
Provides links to information about public meetings, both upcoming and past, on issues pertaining to public health threats, both naturally occurring and manmade. Also included are links to online Meeting Libraries, such as the NIH Videocasting site.
- Strategies and Reports
Provides links to sources of information useful to those involved in the research, development, and acquisition of medical countermeasures products, including Project Bioshield, and Public Health Emergency Medical Countermeasures Enterprise. This section also includes a directory of links to related websites that are developed and maintained by individual Federal Agencies.
Provides links to relevant federal guidance on issues related to the development medical countermeasures, including information on Emergency Use Authorization, the Animal Efficacy Rule, and the Select Agent Rule.
The Federal Government has launched several major initiatives intended to accelerate basic research and development of vaccines, therapeutics, and diagnostics for naturally occurring and manmade threats. This section includes resources that relate to microbiology, immunology and testing, and genomics.
- November 06, 2017
Now Open: 2018 Broad Agency Announcement
- October 24, 2017
CARB-X awards Amicrobe $2.48M to accelerate the development of Amicidin-β topical antimicrobial
- October 06, 2017
HHS sponsors development of drug to treat infections from biowarfare agents, antibiotic-resistant bacteria
- October 06, 2017
HHS pursues therapeutic for radiation injury affecting blood platelets
- October 03, 2017
HHS, Regeneron partner on portfolio of treatments for pandemic influenza, emerging infectious diseases